Capsule-in-capsule

Capsule-in-capsule technology combines advanced formulation solutions with the opportunity to differentiate a product in the premium segment. When is the use of capsule-in-capsule truly justified from a formulation perspective, and what consequences does it have for the production process? We answer these questions.

What is capsule-in-capsule technology?

Capsule-in-capsule technology involves placing one capsule inside another, creating a multilayer system. Each capsule acts as an independent formulation module, making it possible to combine different forms, ingredients, and release profiles in a single dose.

Structure of a “capsule-in-capsule”

The capsule-in-capsule structure is based on two basic elements:

• the outer capsule – which may contain an additional fill (powder, granules, pellets);
• the inner capsule – an independent formulation module that can be designed as an immediate-release or modified-release unit;

Capsule-in-capsule vs. a standard capsule with a composite fill

Capsule-in-capsule technology offers significant design flexibility, allowing the solution to be tailored to specific formulation requirements. The most commonly used variant is a hard capsule inside a hard capsule, e.g. gelatin in gelatin or HPMC in HPMC. Mixed configurations are used less frequently, such as a hard capsule inside a soft capsule or combinations of different shell materials (e.g. gelatin with HPMC or pullulan). Check this to learn more: Types and applications of hard capsules.

In conventional capsules, all ingredients are mixed in one space, which limits their independent optimization and increases the risk of interactions. In a capsule-in-capsule system, each capsule functions as a separate “microsystem,” which enables:

• physical separation of ingredients;
• independent optimization of each phase of the product;
• use of different release mechanisms in a single dose;
• preservation of ingredient integrity until they are released in the body.

Applications of capsule-in-capsule technology

Thanks to the capsule-in-capsule system, it is possible to:

• physically separate chemically or physically incompatible ingredients, e.g. substances that react with each other, are sensitive to moisture or oxygen, or require different microenvironmental conditions;
• design complex release profiles. Unlike classic delayed release, where the delay is achieved through a single technological barrier, in a capsule-in-capsule system each phase can be designed independently. This makes it possible to combine immediate and delayed release, create pulsatile or multiphase profiles, and precisely control the site and timing of the substance’s action.

Capsule-in-capsule technology is particularly useful where conventional encapsulation proves insufficient. This includes market segments such as beauty products and “day & night” supplements, products supporting the digestive system, and supplements for athletes.

Good to know: Capsule-in-capsule technology also makes it possible to combine different physical forms in a single dose, for example powder with pellets, liquid with granules, or a capsule with mini-tablets. This flexibility allows the bioavailability and functionality of the product to be optimized without the need for formulation compromises.

Capsule-in-capsule and marketing

Capsule-in-capsule is not only a technological solution, but also a useful marketing tool. The visible inner capsule, especially in a transparent or semi-transparent outer shell, immediately attracts attention and makes the product stand out on the shelf. Such an appearance is associated with advanced technology and high quality, which directly influences purchasing decisions. The visual effect can be further enhanced through color contrast and by emphasizing concepts such as “dual action” or “multi-phase delivery” in marketing communication.

Good to know: Consumers perceive capsule-in-capsule as a more advanced form than a standard capsule, which justifies a higher retail price. This value results not only from the form itself, but also from functional benefits such as multiphase action, better bioavailability, or convenience of use (one capsule instead of several).

Production requirements of the capsule-in-capsule system

The production of capsule-in-capsule requires an approach based on high precision and strict control of process parameters. Unlike conventional forms, where there is one capsule and one filling stage, this process is more advanced and includes, among other things:

• preparing the inner capsule and then placing it in the outer capsule, with or without an additional fill;
• precise selection of capsule sizes (both inner and outer), taking very narrow dimensional tolerances into account;
• control of fill weight and uniformity at both levels of the structure;
• ensuring the mechanical integrity of the entire system, i.e. the capsule’s resistance to damage during encapsulation, packaging, transport, and storage;
• confirmation of process repeatability, product stability over time, and compliance of the release profile.

In the case of multiphase systems, e.g. with different release rates, the development of analytical methods (in particular dissolution tests) is also more complex and may require differential studies to assess the contribution of individual components. Stability studies are more demanding than for standard capsules and must take into account: potential interactions between capsules, moisture migration, the effect of temperature on mechanical integrity, and changes in the release profile over time.

Capsule-in-capsule – requirements for raw materials and composition

The most commonly used materials in the capsule-in-capsule system are: gelatin, hypromellose (HPMC), and pullulan. Each of them has different properties that directly affect stability and the release profile:

• gelatin provides good mechanical properties and broad availability, but is more sensitive to moisture;
• hypromellose is characterized by lower hygroscopicity and better compatibility with demanding formulations, making it a popular choice in plant-based products;
• pullulan stands out for its very good oxygen barrier properties, which is important for ingredients sensitive to oxidation.

In a dual configuration, not only the individual characteristics of the materials must be considered, but also their mutual compatibility. Differences in water vapor permeability or dissolution rate may lead to moisture migration between capsules, which will negatively affect the stability and release of active substances. Learn more: HPMC vs. pullulan – how vegan shell materials differ.

Volume and weight limitations of capsule-in-capsule technology

A significant limitation of the capsule-in-capsule system is volume. The inner capsule occupies part of the space in the outer capsule, which necessitates optimization of the composition. In practice, this means the need to use more concentrated forms of ingredients or even to compromise between functionality and dose size. Errors in volume or weight can lead to problems with capsule closure, mechanical damage, and a lack of process repeatability, which may have serious consequences.

Regulatory requirements for capsule-in-capsule

The complexity of the capsule-in-capsule form naturally also translates into regulatory and documentation requirements. The technology itself does not automatically change the classification of the product (it may still be a dietary supplement or an OTC product). However, the way supervisory authorities assess it changes:

• in the case of dietary supplements, it is crucial to demonstrate the safety of the ingredients and the compliance of the composition with the declaration;
• in OTC products, there is additionally a need to document efficacy and control the release profile.

Good to know In capsule-in-capsule systems, the following are particularly important: consistency of action across all components and repeatability of the effect.

GMP documentation for capsule-in-capsule must cover each stage of the process separately. Both the preparation of the inner capsule and the final encapsulation are subject to validation. Check what GMP principles are and what they mean in manufacturing practice.

Particular attention is paid to:

• control of capsule integrity;
• process repeatability during scale-up;
• validation of analytical methods capable of assessing multiphase release.

Finally, let us also pay attention to how the product is labeled. In the case of capsule-in-capsule products, communicating technological features such as “biphasic release” or the use of “capsule-in-capsule” technology is permitted, provided that it does not suggest unconfirmed therapeutic effects. All marketing communication must comply with applicable regulations on health and functional claims.

Capsule-in-capsule in contract supplement manufacturing

Capsule-in-capsule technology is not a market standard. This solution works best in premium-segment products that require ingredient separation or complex release. “Capsule-in-capsule” will not always be the optimal choice – for simple formulations or high doses, this method may prove ineffective or unprofitable. In such cases, technological consultation with an experienced contract manufacturer, such as Eubioco, is of key importance.

We help our clients assess the real possibilities of implementation and advise them on selecting the optimal formulation design. We also provide support in the areas of stability studies, analytical methods, and regulatory documentation, as well as the process of bringing the product to market. Check how contract supplement manufacturing works – from brief to finished product at Eubioco. We invite you to cooperate with a contract manufacturing company with over 35 years of experience.

BIBLIOGRAPHY

Manufacturing Chemist (2026). Tablet-in-capsule technology: a versatile platform for complex oral solid dose development. [online] Available at: https://manufacturingchemist.com/tablet-in-capsule-technology-a-versatile-platform-for [accessed online: 17.03.2026]

Rump, A., Weiss, F. N., Schulz, L., Kromrey, M.-L., Scheuch, E., Tzvetkov, M. V., White, T., Durkee, S., Judge, K. W., Jannin, V., Bellamine, A., Weitschies, W., Grimm, M. (2021). The Effect of Capsule-in-Capsule Combinations on In Vivo Disintegration in Human Volunteers: A Combined Imaging and Salivary Tracer Study. Pharmaceutics, 13, 12. https://doi.org/10.3390/pharmaceutics13122002

U.S. Food & Drug Administration (2020). Dietary Supplements Guidance Documents & Regulatory Information. [online]. Available at: https://www.fda.gov/food/guidance-documents-regulatory-information-topic-food-and-dietary-supplements/dietary-supplements-guidance-documents-regulatory-information [accessed online: 17.03.2026]

Wisdom Library (2024). Capsule-in-a-capsule technology: Significance and symbolism. [online]. Available at: https://www.wisdomlib.org/concept/capsule-in-a-capsule-technology [accessed online: 17.03.2026]Yang, N., Chen, H., Jin, Z., Hou, J., Zhang, Y., Han, H., Shen, Y., Guo, S. (2020). Moisture sorption and desorption properties of gelatin, HPMC and pullulan hard capsules. International Journal of Biological Macromolecules, 159, 659-666. https://doi.org/10.1016/j.ijbiomac.2020.05.110.